Skip to content

Effects of ghrelin administration after gastrectomy in patients with gastric cancer: phase II study

Effects of ghrelin administration after gastrectomy in patients with gastric cancer: phase II study - Effects of ghrelin administration after gastrectomy in patients with gastric cancer: phase II study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000008683
Enrollment
10
Registered
2012-08-14
Start date
2009-02-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer patients who underwent gastrectomy

Interventions

Sponsors

Osaka University School of Medicine Gastroenterological Surgery
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) patients with gastric cancer more than 1 year after distal or total gastrectomy 2) with curative surgical resection and without any recurrence 3) with more than 15% body weight loss compared to preoperative body weight or less than 19 of BMI 4) Age>20 and <80 years 5) oral intake possible 6) written informed consent

Exclusion criteria

Exclusion criteria: 1) with severe complication or active dual malignancy 2) judged as inappropriate by physician-in-charge

Design outcomes

Primary

MeasureTime frame
Amount of food intake,postoperative body weight(during 7-days ghrelin administration)

Secondary

MeasureTime frame
Adverse events, appetite VAS, physiolosical examination, clinical blood examination (during 7-days ghrelin administration)

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026